Target intelligence / Profile preview

Immunoglobulin lambda variable (IV)-59 (pseudogene) (IGLVIV-59)

Target
IGLVIV-59
Molecular classification
Other (Pseudogene), Immunoglobulin gene segment (Variable region)
01

Overview

Immunoglobulin lambda variable (IV)-59 (IGLVIV-59) is a pseudogene within the immunoglobulin lambda light chain variable region gene family on chromosome 22. Immunoglobulin variable (V) region gene segments, including functional genes and pseudogenes, provide the raw genetic material for the diversity of antigen-binding sites in antibodies. However, as a pseudogene, IGLVIV-59 does not encode a functional protein product and is not transcribed into a complete immunoglobulin light chain. Such pseudogenes are a common feature in the immunoglobulin loci, reflecting the evolutionary mechanisms that generate antibody diversity[1][3]. There is no evidence of this gene being a target for therapeutics, a direct contributor to disease etiology, or a source of clinical biomarker information[3].

Other names
Immunoglobulin lambda variable (IV)-59IGLV(IV)-59
02

Biological functions

Contributes to genomic diversity in the immunoglobulin lambda light chain locus through germline V segment pseudogene status[1]Does not produce a functional protein[3]
03

Disease associations

Other (no known direct disease association; pseudogenes may sometimes be involved in genomic recombination errors, but this is not specifically reported for IGLVIV-59)

Beyond the preview

Go deeper on Immunoglobulin lambda variable (IV)-59 (pseudogene) (IGLVIV-59).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable (IV)-59 (pseudogene) (IGLVIV-59).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call